• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Drug Self-administration Markets to 2020 - Product Image

Drug Self-administration Markets to 2020

  • ID: 2726756
  • January 2014
  • Greystone Associates

Therapeutic Indications, Product Strategies, Markets and Forecasts

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors are converging to create both risk and opportunity for drug makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, caregiver safety legislation, and continued pressure to control healthcare costs. These factors are giving rise to a new generation of sophisticated, application-specific injection, inhalation and transdermal drug products designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the formulation limitations of new classes of therapeutic drugs. Because of their ability to safely and READ MORE >

Note: Product cover images may vary from those shown

Executive Summary

Drug Market Dynamics

Evolving Drug Development and Market Factors
Managed Care and Prescribing Trends
Drug Self-Administration Demand Factors
Shifting Patient Demographics
Chronic Disease and Self-administration
Biological Drugs Proliferating
Delivery Device Technology & Evolving

Drug Self-Administration Product Segments and Market Drivers

Injectable Drug Self-Administration

Market Sector Dynamics
The Shift to Prefilled Devices
Device Selection Factors
Market Segmentation & Cost
Product Features & Ease of Use
Custom Device Designs & Branding
Prefilled Syringes (PFS)
Glass PFS
Plastic PFS
Prospects for Autoinjectors
Key PFS Therapeutic Segments
The PFS Supply Chain
PFS Supplier Profiles
Pen Injectors
Reusable Pens
Disposable Pens
Key Pen Injector Therapeutic Segments
The Top Ten Pen Injector Drug Products
Five Segments Driving Pen Injector Growth
Pen Injector Company Profiles
Needle-free Injectors (NFI)
Reusable NFI
Competitive NFI Therapeutic Segments
Needle-free Company Profiles

Inhaled Drug Self-Administration Products

Market Sector Dynamics
The Upper Respiratory Market
Established Therapeutic Targets
Dual Drug Inhalers
The Systemic/Deep Lung Market
Established Markets
Emerging Therapies
Inhaler Technology and Market Prospects
Inhaler Product Segments
Dry Powder Inhalers
Device Design Factors
Powder Technology
Packaging Issues
DPI Device Company Profiles
Metered Dose Inhalers
Manual Devices
Breathe Actuated Designs
MDI Device Company Profiles
Established Nebulizer Therapies
Evolving Nebulizer Technology
Nebulizer Device Company Profiles
Performance Factors
Dose Reproducibility
Active Compound Stability

Transdermal Drug Self-Administration

Market Sector Dynamics
Traditional Patch Markets
Emerging Markets
Transdermal Patch Market Drivers
Prescription Patch Design & Technology
Passive Patch Architecture
Passive Transdermal Patch Design
Passive Patch Construction
Active Transport Patch Technologies
Mechanical Arrays
Radio Frequency
Prescription Patch Development Factors
Key Transdermal Therapeutic Markets
Transdermal Product Company Profiles

Drug Self-Administration – Therapeutic Sector Analysis & Forecasts

Cystic Fibrosis
Hormone Therapy/Replacement
Multiple Sclerosis
Pain Management
Sexual Health

Company Profiles

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Our clients' logos